Tag: ic3

Impact of Videregen’s technology recognised as it joins UK’s Social Stock Exchange

New source of capital for company as pipeline develops IC3 tenants Videregen Limited, a clinical stage regenerative medicine company developing personalised organ replacements, is pleased to announce that it has become a member of the UK Social Stock Exchange (SSX), a platform which links up businesses and investors focused on impact investing. The SSX provides… Read more »